Similar Items: Dual-targeted approaches in cancer therapy: integrating siRNA and chemotherapy for improved outcomes
- Divalent siRNA for prion disease
- Conquering Oxygen Heterogeneity in Hepatocellular Carcinoma With a Dual‐Targeted Nanoplatform Integrating Type I Photodynamic Therapy/Starvation Therapy/Hypoxia‐Activated Chemotherapy
- Antivirals Targeting Coronavirus RNA‐Dependent RNA Polymerase and Main Protease: From Mechanisms of Action to Outcomes in COVID‐19 Clinical Trials
- A smart nanocomposite bioactive ink for controlled siRNA delivery in calvarial mesenchymal stromal cells as a minimally invasive treatment for craniosynostosis
- siRNAs, tRNAs, and rRNAs in Osteoarthritis: Biological Functions and Therapeutic Opportunities
- Metalloproteinases in the pathogenesis and progression of metabolic syndrome: potential targets for improved outcomes